NCT01685424View on ClinicalTrials.gov

Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1)

CompletedOBSERVATIONAL

Enrollment

79,189

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

March 1, 2015

Study Completion Date

March 1, 2015

Conditions

OsteoarthritisRheumatoid ArthritisAnkylosing SpondylitisGoutArthritis

Interventions

DRUG

Etoricoxib

As per routine clinical practice in the United Kingdom

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT01685424 - Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1) | Biotech Hunter | Biotech Hunter